Literature DB >> 1295459

Demonstration of monoclonal anti-carcinoembryonic antigen (CEA) antibody internalization by electron microscopy, western blotting and radioimmunoassay.

G Tsaltas1, C H Ford, M Gallant.   

Abstract

One of the important factors affecting the action of monoclonal antibodies (Mabs) or immunoconjugates on tumour sites depends on whether the Mab is internalized by the cancer cells in question. The underexplored subject of internalization is discussed in this paper, and a number of in vitro techniques for investigating internalization are evaluated, using a model which consists of a well characterized anti-carcinoembryonic antigen (anti-CEA) Mab and a number of CEA expressing human cancer cell lines. Employing two alternative radiolabeling assays, evidence for internalization of the anti-CEA Mab by a CEA-positive colorectal cancer cell line (LS174T) was obtained throughout the time intervals examined (5 min to 150 min). Electronmicroscopy employing horseradish-peroxidase labeled anti-CEA Mab and control antibody permitted direct visualization of anti-CEA Mab-related staining in intracellular compartments of a high CEA-expressor human colorectal cell line (SKCO1). Finally Western blots of samples derived from cytosolic and membrane components of solubilized cells from lung and colonic cancer cell lines provided evidence for internalized anti-CEA Mab throughout seven half hour intervals, starting at 5 minutes. Internalized anti-CEA was detected in all CEA expressing cell lines (LS174T, SKCO1, BENN) but not in the case of a very low CEA expressor line (COLO 320).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1295459

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  A novel homogeneous time-resolved fluoroimmunoassay for carcinoembryonic antigen based on water-soluble quantum dots.

Authors:  Zhen-Hua Chen; Ying-Song Wu; Mei-Jun Chen; Jing-Yuan Hou; Zhi-Qi Ren; Da Sun; Tian-Cai Liu
Journal:  J Fluoresc       Date:  2013-03-08       Impact factor: 2.217

2.  CEACAM5-targeted therapy of human colonic and pancreatic cancer xenografts with potent labetuzumab-SN-38 immunoconjugates.

Authors:  Serengulam V Govindan; Thomas M Cardillo; Sung-Ju Moon; Hans J Hansen; David M Goldenberg
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

3.  Screen-printed electrode produced by printed-circuit board technology. Application to Cancer Biomarker Detection by means of plastic antibody as sensing material.

Authors:  Felismina T C Moreira; M Judite M S Ferreira; José R T Puga; M Goreti F Sales
Journal:  Sens Actuators B Chem       Date:  2016-02       Impact factor: 7.460

4.  Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.

Authors:  Steve Knutson; Erum Raja; Ryan Bomgarden; Marie Nlend; Aoshuang Chen; Ramaswamy Kalyanasundaram; Surbhi Desai
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.